MOLN – molecular partners ag - american depositary shares (US:NASDAQ)
Stock Stats
News
Molecular Partners (NASDAQ:MOLN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action [Yahoo! Finance]
Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action
Molecular Partners (NASDAQ:MOLN) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
Form 6-K MOLECULAR PARTNERS AG For: Nov 12
Form 6-K MOLECULAR PARTNERS AG For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.